Molecule Details
InChIKeyYEVVFVQVGXPEQO-YYACYCFASA-N
Compound Nametert-butyl N-[2-[bis[3-[2-[[6-[5-[[(2R)-3-hydroxy-1-(hydroxyamino)-1-oxopropan-2-yl]-(4-methoxyphenyl)sulfonylamino]pentylamino]-6-oxohexanoyl]amino]ethylamino]-3-oxopropyl]amino]ethyl]carbamate
Canonical SMILESCOc1ccc(S(=O)(=O)N(CCCCCNC(=O)CCCCC(=O)NCCNC(=O)CCN(CCNC(=O)OC(C)(C)C)CCC(=O)NCCNC(=O)CCCCC(=O)NCCCCCN([C@H](CO)C(=O)NO)S(=O)(=O)c2ccc(OC)cc2)[C@H](CO)C(=O)NO)cc1
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)5
Pfam Stratification Homologous
Avg pChEMBL7.45
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
Target Activities (5)
Target Gene Organism Category Pfam pChEMBL Type Source
P08253 MMP2 Homo sapiens Human PF00040 PF00045 PF00413 7.8 Ki ChEMBL;BindingDB
P14780 MMP9 Homo sapiens Human PF00040 PF00045 PF00413 7.7 Ki ChEMBL;BindingDB
P39900 MMP12 Homo sapiens Human PF00045 PF00413 PF01471 7.6 Ki ChEMBL;BindingDB
P45452 MMP13 Homo sapiens Human PF00045 PF00413 PF01471 7.2 Ki ChEMBL;BindingDB
P03956 MMP1 Homo sapiens Human PF00045 PF00413 PF01471 6.8 Ki ChEMBL;BindingDB